GeneralConnection.com ➔ Dictionary
Dictionary Search

vasomotor

Synonyms

Adjective

1. constriction

2. dilation, dilatation

Usage
FDA says "study may proceed" for Vistagen's refisolone nasal spray for vasomotor symptoms - Contemporary OB/GYN
Neurokinin receptor antagonists for vasomotor symptoms: from KNDy neurons to clinical translation - Nature
Vistagen Receives FDA “Study May Proceed” Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause - BioSpace
Elinzanetant: Advancing Treatment for Vasomotor Symptoms - Pharmacy Times
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer - New England Journal of Medicine
Lynkuet (elinzanetant) for the Treatment of Vasomotor Symptoms Due to Menopause - Rheumatology Advisor
How African American Patients Are Affected By Vasomotor Symptoms - Patient Care Online
U.S. approval of a new hormone-free treatment option for moderate to severe vasomotor symptoms due to menopause - Bayer
Estetrol Improves Vasomotor Symptoms With No BP Effects - Medscape
Risk factors, management and consequences of severe menopausal vasomotor symptoms - Nature
Pathophysiology of Vasomotor Symptoms in Menopause - Patient Care Online
Fezolinetant shows significant real-world improvements in vasomotor symptoms, sleep - Contemporary OB/GYN
Pooled Safety Analysis Supports Elinzanetant for Vasomotor Symptoms Through 52 Weeks - Patient Care Online
Pathophysiology of Vasomotor Symptoms in Menopause - Contemporary OB/GYN
Closing the Gap: Elinzanetant Demonstrates Efficacy for Vasomotor Symptoms in African American Women - Contemporary OB/GYN
Elinzanetant Demonstrates Rapid and Sustained Efficacy in Reducing Vasomotor Symptoms Across OASIS Clinical Trials - Pharmacy Times
Special Report: Managing vasomotor symptoms in menopause - Contemporary OB/GYN
Lisa Larkin, MD, on the Importance of Recognizing and Managing Vasomotor Symptoms in Menopause - Patient Care Online
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms - Pharmacy Times
Elinzanetant Reduces Postmenopausal Sleep Disturbances Independent of Improvements in Vasomotor Symptoms - Medscape
EU approval for new hormone-free treatment option for vasomotor symptoms associated with menopause or caused by endocrine therapy for breast cancer - Bayer
FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms - Contemporary OB/GYN
Vasomotor Symptoms Are Linked to Vascular and Cartilage Structural Changes in Postmenopausal Women - Wiley
Vasomotor Symptoms and Adjuvant Endocrine Therapy: Burden and Available Evidence - EMJ
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD - AJMC
Impact of Vasomotor Symptoms on Patient Quality of Life - Patient Care Online
Elinzanetant for Vasomotor Symptoms From Endocrine Therapy for Breast Cancer - The ASCO Post
Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms - Patient Care Online
FDA extends review period for Bayer's elinzanetant for vasomotor symptoms - Contemporary OB/GYN
FDA Approves Elinzanetant for Moderate-to-Severe Vasomotor Symptoms of Menopause: Daily Dose - Patient Care Online
Noema Pharma Announces Phase 2a Study Results with - GlobeNewswire
New nonhormonal therapies transform hot flash treatment in menopause - Contemporary OB/GYN
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause - AJMC
Special Report: How neurokinin receptor antagonists are reshaping the VMS treatment landscape - Contemporary OB/GYN
Hormone Therapy Does Not Increase Cardiovascular Disease Risk in Younger Postmenopausal Women - Northwestern University
Bayer receives FDA approval for non-hormonal menopause therapy - BioPharma Dive
Fezolinetant Can Reduce Menopause Symptoms in Women Who Cannot or Will Not Take Hormone Therapy - American Academy of Family Physicians | AAFP
NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats - PharmaTimes
Association between modified mediterranean diet score and menopause-specific quality of life and symptoms: a cross-sectional study | Scientific Reports - Nature
FDA Green-Lights Elinzanetant, First Dual NK-1/NK-3 Antagonist, for Moderate to Severe Vasomotor Symptoms of Menopause - Patient Care Online
New Data Show Elinzanetant Is a Safe, Well-Tolerated Nonhormonal Therapy for Menopausal Vasomotor Symptoms - Pharmacy Times
Special Report: Identifying gaps in care - Contemporary OB/GYN
How New Pathways Are Easing Vasomotor Symptoms in Breast Cancer Care - Contemporary OB/GYN
Elinzanetant recommended for approval in EU as treatment of moderate to severe vasomotor symptoms - Bayer
Elinzanetant Eases Vasomotor Symptoms in HR+ Breast Cancer - Docwire News
Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD - Contemporary OB/GYN
Navigating Vasomotor Symptoms From Endocrine Therapy in Breast Cancer Treatment - Contemporary OB/GYN
New study may offer hope to women suffering menopausal hot flashes, night sweats - Medical Xpress
VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer - 2 Minute Medicine
Special Report: Recent advancements in pharmacologic and nonpharmacologic treatment options - Contemporary OB/GYN
Plant-Based Estrogen Diminished Menopause Symptoms - MedPage Today
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies - AJMC
Dr Cardoso on the Effect of Elinzanetant on Vasomotor Symptoms in HR+ Breast Cancer - OncLive
Menopause drug reduces hot flashes by more than 70%, international clinical trial finds - Medical Xpress
Elinzanetant significantly reduces frequency of moderate to severe vasomotor symptoms associated with endocrine therapy for breast cancer in Phase III OASIS-4 study - Bayer
Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine - JACC Journals
New menopause drug to target hot flashes without hormones gets FDA approval - ABC7 New York
Novel Nonhormonal Drug Approved for Menopause Hot Flashes - MedPage Today
Elinzanetant Reduces Frequency, Severity of VMS in Differing Female Populations - Pharmacy Times
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause - Yahoo Finance
Elinzanetant found to reduce VMS from endocrine therapy for breast cancer - Contemporary OB/GYN
newsGP - Vasomotor symptoms key to perimenopause diagnosis - Royal Australian College of General Practitioners (RACGP)
OASIS-4 Trial: Elinzanetant Reduces Frequency of Vasomotor Symptoms Related to Endocrine Therapy for HR-Positive Breast Cancer - Patient Care Online
Elinzanetant Demonstrates Clinically Meaningful Reductions in Menopausal Vasomotor Symptoms, Meta-analysis Shows - Patient Care Online
Phase III OASIS-4 Trial Shows Elinzanetant Significantly Reduces Endocrine Therapy–Related Vasomotor Symptoms in Patients with HR-Positive Breast Cancer - Applied Clinical Trials Online
Vasomotor Symptoms of Menopause: Facts At-a-Glance for Primary Care - Patient Care Online
Narcolepsy Patients Show Enhanced Brain Waste Clearance Through Compensatory Vasomotor Activity - Sleep Review
How a Mediterranean diet helps women manage menopausal symptoms - News-Medical
Acta Obstetricia et Gynecologica Scandinavica | NFOG Women's Health Journal | Wiley Online Library - Wiley
Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy - Medical Xpress
An update on the use of non-hormonal therapies for vasomotor symptoms of menopause - Royal Australian College of General Practitioners (RACGP)
With FDA nod, Bayer's Lynkuet enters US market for nonhormonal menopause symptom meds - Fierce Pharma
Fezolinetant shows real-world promise for menopause symptoms - PharmaTimes
OASIS-4 trial: Efficacy and safety of elinzanetant for vasomotor symptoms associated with adjuvant endocrine therapy in women with breast cancer - EMJ
MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms (hot flushes) caused by menopause - GOV.UK
FDA Extends Review Period for Bayer’s Elinzanetant for Moderate to Severe Menopausal Symptoms - Pharmaceutical Executive
Many physicians still consider VMS to be transient and inconsequential, but new research suggests otherwise—are you all caught up? - MDLinx
AbCellera begins Phase II ABCL635 trial for menopause-related VMS - Clinical Trials Arena
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study - The Lancet
‘Ignoring hot flushes is wrong’: study challenges assumptions about perimenopause symptoms - The Guardian
Singapore Approves Astellas’ VEOZA™ (Fezolinetant) for Moderate to Severe Menopausal Vasomotor Symptoms - BioPharma APAC
Bayer drug could ease side effects of common breast cancer treatment, detailed data show - BioPharma Dive
Bayer Receives First Global Approval for Lynkuet to Treat Menopause Vasomotor Symptoms - Femtech Insider
Bayer scores first approval for hormone-free menopause drug Lynkuet in UK - Fierce Pharma
2023 Menopause Society Annual Meeting Highlights Vasomotor Symptoms Treatment - Endocrinology Advisor
Bayer Elinzanetant recommended for nod in EU for moderate to severe vasomotor symptoms - Medical Dialogues
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer - University College Dublin
Elinzanetant Excels in Phase 3 Study for Vasomotor Symptom Relief - AJMC
Abcellera gains Canadian clearance for phase I study of ABCL-635 for vasomotor symptoms in menopause - BioWorld News
FDA accepts elinzanetant NDA for vasomotor symptoms in menopause - Contemporary OB/GYN
Fezolinetant significantly reduces vasomotor symptoms in post-menopausal women - 2 Minute Medicine
Best nonhormone methods for managing vasomotor symptoms - Contemporary OB/GYN
How Do Vasomotor Symptoms Affect the Body? - Healthline
Two types of vidian neurectomy show efficacy in treating allergic rhinitis and vasomotor rhinitis - Nature
Vasomotor symptom frequency linked to diabetes risk - Contemporary OB/GYN
Nonpharmacologic Options Can Manage Hot Flashes - Medscape
Neurokinin 3 receptor antagonists for menopausal vasomotor symptoms - The Lancet
Human NREM Sleep Promotes Brain-Wide Vasomotor and Respiratory Pulsations - Journal of Neuroscience
Nighttime vasomotor symptoms linked to Alzheimer's risk - Contemporary OB/GYN
Pharmacologic treatment options for vasomotor symptoms - Contemporary OB/GYN
Foreign Language Equivalents
Foreign Language Equivalents of 'vasomotor'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
vassomotor,   vasomoto,   vadomotor,   casomotor,   vasomotro,   avsomotor,   vasomootr,   vasomotot,   vasomootor,   vaomotor,   asomotor,   vasomtor,   vasomoter,   vasommotor,   vasomtoor,   vasoomotor,   basomotor,   vaasomotor,   vasoomtor,   vaaomotor,   vasomotpr,   vasmootor,   vasootor,   vaspmotor,   vvasomotor,   vasonotor,   vasomoror,   vasomottor,   vasmotor,   vasomotir,   vsaomotor,   vasimotor,   vasomoor,   vssomotor,   vasomotoor,   vasomitor,   vasomotr,   vaosmotor,   vasomotorr,   vasomptor,   vasomotoe,   vasomoyor,   vaso,otor,   vsomotor
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z